QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
Log in
LON:GSK

GlaxoSmithKline Share Forecast, Price & News

GBX 1,479.60
-8.00 (-0.54 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
1,470.40
Now: GBX 1,479.60
1,499
50-Day Range
1,435.20
MA: GBX 1,520.61
1,611.60
52-Week Range
1,328.19
Now: GBX 1,479.60
1,857
Volume5.38 million shs
Average Volume8.67 million shs
Market Capitalization£74.24 billion
P/E Ratio11.15
Dividend Yield5.01%
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Sensodyne, parodontax, Poligrip, Voltaren, Panadol, Otrivin, and Theraflu brand names. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, pods, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, and malted drinks and foods. Its primary collaboration is with 23andMe; and strategic alliance is with Merck KGaA to jointly develop and commercialize M7824. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Read More
GlaxoSmithKline logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 1.9Dividend Strength: 2.5Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.35 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-80475000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£35.00 billion
Cash FlowGBX 160.89 per share
Book ValueGBX 273.10 per share

Profitability

Miscellaneous

Employees95,490
Outstanding Shares5,017,359,872
Market Cap£74.24 billion
Next Earnings Date10/28/2020 (Estimated)
OptionableOptionable
GBX 1,479.60
-8.00 (-0.54 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











GlaxoSmithKline (LON:GSK) Frequently Asked Questions

How has GlaxoSmithKline's stock been impacted by Coronavirus?

GlaxoSmithKline's stock was trading at GBX 1,522.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GSK shares have decreased by 2.8% and is now trading at GBX 1,479.60.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of GlaxoSmithKline?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 3 sell ratings, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for GlaxoSmithKline
.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for GlaxoSmithKline
.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) issued its quarterly earnings data on Wednesday, July, 29th. The company reported $56.90 earnings per share (EPS) for the quarter.
View GlaxoSmithKline's earnings history
.

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline declared a dividend on Wednesday, July 29th. Shareholders of record on Thursday, August 13th will be paid a dividend of GBX 19 per share on Thursday, October 8th. This represents a dividend yield of 1.22%. The ex-dividend date is Thursday, August 13th. The official announcement can be viewed at this link.
View GlaxoSmithKline's dividend history
.

What price target have analysts set for GSK?

17 analysts have issued 1 year price objectives for GlaxoSmithKline's shares. Their forecasts range from GBX 1,550 to GBX 2,240. On average, they expect GlaxoSmithKline's stock price to reach GBX 1,830.20 in the next twelve months. This suggests a possible upside of 23.7% from the stock's current price.
View analysts' price targets for GlaxoSmithKline
.

Has GlaxoSmithKline been receiving favorable news coverage?

Media stories about GSK stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. GlaxoSmithKline earned a news sentiment score of 1.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about GlaxoSmithKline
.

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AstraZeneca (AZN), General Electric (GE), Royal Dutch Shell (RDSB), Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), AT&T (T), Vodafone Group (VOD) and Johnson & Johnson (JNJ).

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the following people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 49)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56)
  • Mr. Simon P. Dingemans, Exec. Director (Age 55)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 57)

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,479.60.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £74.24 billion and generates £35.00 billion in revenue each year. GlaxoSmithKline employs 95,490 workers across the globe.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is www.gsk.com.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.